Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry Greenberg

Showing results (111-120 of 189) with videos related to

Pageof 19
Sort By:
Congestive Heart Failure (Greenwich, Conn.)|December 16, 2006
Heart failure in community practice: relationship to age and sex in a beta-blocker registryJoseph A Franciosa, Jeanenne J Nelson, Mary Ann Lukas, et al.
The American Journal of Cardiology|May 5, 2007
Comparison of outcomes and usefulness of carvedilol across a spectrum of left ventricular ejection fractions in patients with heart failure in clinical practiceBarry M Massie, Jeanenne J Nelson, Mary Ann Lukas, et al.
American Heart Journal|June 2, 2007
Beta-blocker dosing in community-based treatment of heart failureMichael B Fowler, Sandra R Lottes, Jeanenne J Nelson, et al.
Psychosomatic Medicine|May 18, 2016
Pilot Randomized Study of a Gratitude Journaling Intervention on Heart Rate Variability and Inflammatory Biomarkers in Patients With Stage B Heart FailureLaura S Redwine, Brook L Henry, Meredith A Pung, et al.
The American Journal of Cardiology|November 28, 2006
Predictors of clinical outcomes in patients given carvedilol for heart failureBarry Greenberg, Sandra R Lottes, Jeanenne J Nelson, et al.
Journal of Cardiac Failure|March 31, 2009
Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trialBrian E Jaski, Mariell L Jessup, Donna M Mancini, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 30, 2009
Scales as outcome measures for Alzheimer's diseaseRonald Black, Barry Greenberg, J Michael Ryan, et al.
Journal of Cardiac Failure|May 4, 2026
Patient Perspectives on Cardiac Gene Therapy: A Survey of Knowledge, Attitudes, and Educational NeedsElizabeth Silver, Adam Taub, Vivian Bui, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 9, 2024
Hypokalaemia in patients with type 2 diabetes and chronic kidney disease: the effect of finerenone-a FIDELITY analysisBertram Pitt, Rajiv Agarwal, Stefan D Anker, et al.
Journal of the American College of Cardiology|April 6, 2005
Echocardiographic predictors of morbidity and mortality in patients with advanced heart failure: the Beta-blocker Evaluation of Survival Trial (BEST)Paul A Grayburn, Christopher P Appleton, Anthony N DeMaria, et al.
Pageof 19

Showing results (111-120 of 189) with videos related to

Sort By:
Pageof 19
Congestive Heart Failure (Greenwich, Conn.)|December 16, 2006
Heart failure in community practice: relationship to age and sex in a beta-blocker registryJoseph A Franciosa, Jeanenne J Nelson, Mary Ann Lukas, et al.
The American Journal of Cardiology|May 5, 2007
Comparison of outcomes and usefulness of carvedilol across a spectrum of left ventricular ejection fractions in patients with heart failure in clinical practiceBarry M Massie, Jeanenne J Nelson, Mary Ann Lukas, et al.
American Heart Journal|June 2, 2007
Beta-blocker dosing in community-based treatment of heart failureMichael B Fowler, Sandra R Lottes, Jeanenne J Nelson, et al.
Psychosomatic Medicine|May 18, 2016
Pilot Randomized Study of a Gratitude Journaling Intervention on Heart Rate Variability and Inflammatory Biomarkers in Patients With Stage B Heart FailureLaura S Redwine, Brook L Henry, Meredith A Pung, et al.
The American Journal of Cardiology|November 28, 2006
Predictors of clinical outcomes in patients given carvedilol for heart failureBarry Greenberg, Sandra R Lottes, Jeanenne J Nelson, et al.
Journal of Cardiac Failure|March 31, 2009
Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trialBrian E Jaski, Mariell L Jessup, Donna M Mancini, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 30, 2009
Scales as outcome measures for Alzheimer's diseaseRonald Black, Barry Greenberg, J Michael Ryan, et al.
Journal of Cardiac Failure|May 4, 2026
Patient Perspectives on Cardiac Gene Therapy: A Survey of Knowledge, Attitudes, and Educational NeedsElizabeth Silver, Adam Taub, Vivian Bui, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 9, 2024
Hypokalaemia in patients with type 2 diabetes and chronic kidney disease: the effect of finerenone-a FIDELITY analysisBertram Pitt, Rajiv Agarwal, Stefan D Anker, et al.
Journal of the American College of Cardiology|April 6, 2005
Echocardiographic predictors of morbidity and mortality in patients with advanced heart failure: the Beta-blocker Evaluation of Survival Trial (BEST)Paul A Grayburn, Christopher P Appleton, Anthony N DeMaria, et al.
Pageof 19